Gleason Shane Thomas's Form 4 filing
InspireMD, Inc. (NSPR) · filed May 21, 2026
- Accession no.
- 0001493152-26-024864
- Filed
- May 21, 2026
- Trade date
- Jan 27, 2025-May 19, 2026
- Filing delay
- 479 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 14 non-derivative transactions and 0 derivative transactions. Open-market sales total $189.6K. It was filed 479 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gleason Shane ThomasCIK 0001966214 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 27, 2025 | Common Stock | SSaleDisposed | −3,858 | $2.71 | −$10,455.18 | 1,135,319 | Direct | |
| Jan 28, 2025 | Common Stock | SSaleDisposed | −2,476 | $2.61 | −$6,462.36 | 1,132,843 | Direct | |
| Jan 29, 2025 | Common Stock | SSaleDisposed | −3,660 | $2.46 | −$9,003.6 | 1,129,183 | Direct | |
| Jan 30, 2025 | Common Stock | SSaleDisposed | −2,454 | $2.51 | −$6,159.54 | 1,126,729 | Direct | |
| Jan 31, 2025 | Common Stock | SSaleDisposed | −9,923 | $2.55 | −$25,303.65 | 1,116,806 | Direct | |
| Feb 3, 2025 | Common Stock | SSaleDisposed | −7,073 | $2.51 | −$17,753.23 | 1,109,733 | Direct | |
| Feb 4, 2025 | Common Stock | SSaleDisposed | −5,132 | $2.46 | −$12,624.72 | 1,104,601 | Direct | |
| Feb 25, 2025 | Common Stock | SSaleDisposed | −10,000 | $3.65 | −$36,500 | 1,094,601 | Direct | |
| May 23, 2025 | Common Stock | SSaleDisposed | −2,482 | $2.51 | −$6,229.82 | 1,092,119 | Direct | |
| May 27, 2025 | Common Stock | SSaleDisposed | −1,572 | $2.51 | −$3,945.72 | 1,090,547 | Direct | |
| May 29, 2025 | Common Stock | SSaleDisposed | −3,760 | $2.51 | −$9,437.6 | 1,086,787 | Direct | |
| May 30, 2025 | Common Stock | SSaleDisposed | −7,186 | $2.51 | −$18,036.86 | 1,079,601 | Direct | |
| Feb 2, 2026 | Common Stock | SSaleDisposed | −2,941 | $1.59 | −$4,676.19 | 1,076,660 | Direct | |
| May 19, 2026 | Common Stock | SSaleDisposed | −22,778 | $1.01 | −$23,005.78 | 1,053,882 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.